Post-Market Clinical Follow-up Registry of Patients With CODMAN CERTAS Plus Programmable Valves
Post-Market Clinical Follow-up Registry of Patients With CODMAN CERTAS Plus Programmable Valves
Post-Market Clinical Follow-up Registry of Patients with CODMAN CERTAS Plus Programmable Valves.
The CODMAN CERTAS Plus Programmable Valve is a single use implantable device designed for shunting cerebrospinal fluid (CSF) for the treatment of hydrocephalus.
The clinical investigation specifically aims to collect data on the performance measures outlined below. Data will be collected per standard of care, given the nature of the clinical investigation to capture real world data (registry); timing, frequency, and methodology of assessing the performance outcomes may therefore differ per center, subject, and/or visit.
1) Improvement of the following symptoms related to hydrocephalus:
Inclusion Criteria:
Exclusion Criteria:
N/A